外场下压力及屏蔽对无限深量子阱中施主结合能的影响

考虑外加磁场、压力及屏蔽效应,利用变分方法数值计算GaN/AlxGa1-xN无限深量子阱系统中的杂质态结合能。给出结合能随磁场和阱宽的变化关系,同时讨论了有无屏蔽时的区别。结果表明:在磁场和压力作用下,结合能随阱宽的增大而减小;阱宽和压力一定时,结合能随磁场的增大而增大。屏蔽效应使得有效库仑吸引作用减弱而导致杂质态结合能显著下降。屏蔽效应对结合能的影响随压力增大而增强,随磁场强度增大而减弱。     

Evolution of excess electron binding motifs under both internal‐push (from exo C–F bonds) and external‐push (from endo C–F bonds) electron effects in endohedral metallofullerenes with endo C–F bonds

How does the endo C–F bond influence the excess electron binding motif? For lithium‐doped endohedral perfluorofullerenes with endo C–F bonds, under both internal‐push (from exo C–F bonds) and external‐push (from endo C–F bonds) electron effects, the singly occupied molecular orbital electron cloud of the sphere‐like Li···F₈@C₆₀F₅₂ (D₂) is partially dispersed within the σ_p–s antibonding orbital of endo C–F bonds and the space between C^δ+–F_endo^δ– double electric layers, which makes Li···F₈@C₆₀F₅₂ have partial excess electron (electride characteristics) and partial lithium salt characteristics, while in the tube‐like Li···F₂@C₆₀F₅₈ (C_s), as the Li is changing from approaching F to keeping away from F and to approaching another one, the singly occupied molecular orbital electron cloud is mainly dispersed from within the p orbital of the short endo C–F bond to within the middle of the two F atoms and again to within the p orbital of the short endo C–F bond, which indicates an evolution from lithium salt characteristic to excess electron characteristic, and again to lithium salt characteristic. Copyright © 2012 John Wiley & Sons, Ltd.     

Mixed ligand Cu(II) complexes containing o-vanillin-l-tryptophan Schiff base and heterocyclic nitrogen bases: synthesis,structural characterization,and biological properties

[Cu(L)] (1) and mixed ligand copper(II) complexes [Cu(L)(A)] (2 and 3), where L is the Schiff base derived from o-vanillin and l-tryptophan and A is pyridine (2) and imidazole (3), were synthesized and characterized using conventional and spectral techniques. 2 was structurally characterized using single crystal X-ray crystallography showing that Cu(II) is coordinated through N₂O₂ donors in a square plane. The EPR spectra of the complexes in frozen solution support a square-based structure. Electrochemical behavior of the complexes has been studied by cyclic voltammetry. The DNA-binding properties of L and 1–3 with calf thymus DNA were investigated by spectral and kinetic methods. For all the complexes, the maximum value of binding constant (0.38 × 10⁶) was achieved with 3 by spectroscopic titration. The ability of compounds to break pUC19 DNA was checked by gel electrophoresis. The ligand and copper complexes exert cytotoxicity against MCF-7 cell line.     

Synthesis,structure, and DNA-binding properties of manganese(II) and nickel(II) complexes with tris(N-ethylbenzimidazol-2-ylmethyl)amine ligand

Tris(N-ethylbenzimidazol-2-ylmethyl)amine (Etntb), [Mn(Etntb)(DMF)(H₂O)](pic)₂ (1), and [Ni(Etntb)(DMF)(H₂O)](pic)₂ (2) (pic?=?picrate) have been synthesized and characterized by elemental analyses, molar conductivities, UV–Visible spectra, and IR spectra. Single-crystal X-ray diffraction revealed that the complexes have the same arrangement with distorted octahedral coordination geometries. DNA-binding properties of the free ligand, 1, and 2 have been investigated by electronic absorption, fluorescence, and viscosity measurements. The results suggest that the ligand and its complexes bind DNA via intercalation, and their binding affinity for DNA follows the order 2?>?1?> ligand.     

Cobalt(II) complexes with thiosemicarbazone as potential antitumor agents: synthesis,crystal structures,DNA interactions,and cytotoxicity

Two cobalt(II) complexes [Co(QCT)₂]·Cl·1.5H₂O (1) (QCT = quinoline-2-carboxaldehyde thiosemicarbazone) and [Co(QCMT)(CH₃OH)Cl₂] (2) (QCMT = quinoline-2-carboxaldehyde N⁴-methyl-thiosemicarbazone) have been synthesized and structurally characterized. Complex 1 crystallizes in a triclinic system with space group P–1 and complex 2 crystallizes in a monoclinic system with space group P2(1)/n. In both complexes the cobalt(II) center is six coordinated with distorted octahedral geometry. The interactions of two complexes with CT-DNA were investigated by electronic absorption spectra, circular dichroism (CD) spectra and fluorescence spectra. Results suggest that the complexes bind to DNA via groove binding mode, and complex 2 has stronger binding ability than complex 1. The in vitro cytotoxicity has been tested against the human lung adenocarcinoma cell line A-549, cisplatin-resistant cell line A-549/CDDP, and human breast adenocarcinoma cell line MCF-7. Complex 2 is more cytotoxic than complex 1, and both of them show higher cytotoxicity than the parent ligands alone. Compared with cisplatin, the two cobalt(II) complexes are more active against A-549/CDDP and MCF-7 cell lines at most experimental concentrations. Notably, although complex 2 is found to be less effective than cisplatin against the parent cell line A-549, it is much more effective than cisplatin against the resistant cell A-549/CDDP.     

New supramolecular ferrocene incorporated N,N′-disubstituted thioureas: synthesis,characterization, DNA binding,and antioxidant studies

Ferrocene incorporated N,N′-disubstituted thioureas (S1–S6) were synthesized by allowing 4-ferrocenyl-3-methylaniline to react with freshly prepared aliphatic isothiocyanates and were characterized by using different analytical techniques. Based on single-crystal X-ray analysis compound S1 shows supramolecular structure mediated by secondary bonding interactions, intermolecular hydrogen bonding NH–O, NH–S, and secondary non-covalent interactions (π–H). Voltammetric measurements were used to study their redox behavior and DNA binding of the compounds. Different binding parameters like binding constants, binding energies, and diffusion coefficients (D_o) were calculated for further insight on the affinity with DNA. All the compounds show electrostatic mode of interactions. The D_o of molecule-DNA adducts were found to be lower than that of free molecule. Compounds S1–S6 having 50% inhibition values less than 37.89?μg?mL^?1 indicate that they may have value as antioxidants to be used as therapeutic agents.     

Synthesis,structure, and DNA binding of three reduced amino-acid Schiff-base zinc(II), nickel(II), and cadmium(II) complexes

Three new reduced amino-acid Schiff-base complexes, [Zn(HL)₂] · H₂O (1), [Ni(HL)₂] · H₂O (2), and [Cd(HL)₂] · H₂O (3), where H₂L is a reduced Schiff base derived from condensation of N-(2-hydroxybenzaldehyde) and L-histidine, have been synthesized and characterized by elemental analysis, UV-Vis absorption spectra and single crystal X-ray diffraction. Complexes 1–3 are isostructural. All metal centers are six-coordinate with O₂N₄ donor sets in slightly distorted octahedra. Unlike its Schiff-base counterpart, the deprotonated monoanionic ligand HL^? has a more flexible backbone and two HL^? are tridentate to one metal. Moreover, the binding interactions of these complexes with calf thymus DNA (CT-DNA) have been investigated by UV-Vis spectra and fluorescence quenching, which show that the complexes bind in an intercalative mode.     

An anticancer metallobenzylmalonate: crystal structure and anticancer activity of a palladium complex of 2,2′-bipyridine and benzylmalonate

The novel metallobenzylmalonate [Pd(bipy)(bmal)]?·?2H₂O (bipy?=?2,2′-bipyridyl, bmal?= benzylmalonate) has been synthesized and structurally characterized by element analyses, electronic spectroscopy, electrophoresis and single-crystal X-ray diffraction. The complex is orthorhombic, space group Pna2₁, with a?=?7.637(2), b?=?13.018(4), c?=?20.961(7)?Å, V?=?2083.8(12)?ų, Z?=?4. Pd(1) is four coordinated by two nitrogen atoms from the bipy ligand and two oxygen atoms from bmal with square planar geometry. In the lattice, π–π stacking and hydrogen bonding are the main intermolecular interactions and propitious for non-covalent insertion into DNA molecules. Electronic spectra confirm that the main reaction mode of the compound with DNA is non-covalent. Electrophoresis shows the cleavage of both supercoiled and circular DNA to form small molecular fragments under the action of the complex. The complex shows excellent anti-cancer activity towards lung cancer AGZY-83a.     

Iron(II) complexes containing the 2,6-bis-iminopyridyl moiety. Synthesis,characterization, reactivity,and DNA binding

Two iron(II) complexes, [Fe^II(py^tBuN₃)₂](FeCl₄) (1) and [Fe^II(py^tBuMe₂N₃)Cl₂] (2), with sterically constrained py^tBuN₃ and py^tBuMe₂N₃ chelate ligands (py^tBuN₃ = 2,6-bis-(aldiimino)pyridyl; py^tBuMe₂N₃ = 2,6-bis-(ketimino)pyridyl), have been synthesized and characterized by elemental analysis, IR, UV–vis spectra, and preliminary X-ray single-crystal diffraction. The latter revealed that Fe(II) in 1 is six-coordinate by six nitrogen donors from two bisiminopyridines in a distorted octahedron. Complex 2 reacts with thiourea with a second-order rate constant k₂ = (2.50 ± 0.05) × 10^?3 M^?1 s^?1 at 296 K, and the reaction seemed to be slow. In a similar way, the interaction of 2 and DNA was studied by fluorescence and absorption spectroscopy. The results revealed that 2 caused fluorescence quenching of DNA through a dynamic quenching procedure. The binding constants K_A, K_app, and K_SV as well as the number of binding sites between 2 and DNA were determined.